Records containing: Ovarian Cancer
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2009-03-27Phase II Study of Gemcitabine Plus Cisplatin as First-Line Therapy in Patients With Epithelial Ovarian Cancer
-
CLINICAL_TRIALS study record update · 2009-03-03The Role of Regulatory T Cell in Ovarian Cancer: Focus on Relationship Between
-
CLINICAL_TRIALS study record update · 2009-03-03Safety and Immunogenicity of Cholesterol-Bearing Hydrophobized Pullulan HER2 Protein 146 (CHP-HER2) and NY-ESO-1 Protein (CHP-NY-ESO-1) in Combination With OK-432 in HER2- and/or NY-ESO-1-Expressing Cancers
-
CLINICAL_TRIALS study record update · 2009-03-03Screening and Identification of Novel Diagnostic and Prognostic Biomarkers on Ovarian Cancers
-
CLINICAL_TRIALS study record update · 2009-02-17Assessment of the Impact of Preoperative Stress Reduction on Psychological, Physiological and Immunological Parameters in Women With Gynecological Malignancies - Prospective Randomized Controlled Trial
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2009-02-13Randomized, Phase 2 Study of Pegfilgrastim Given on the Last Day of a Multi-Day Topotecan Regimen or the Day After in Subjects With Relapsed or Refractory Ovarian Cancer
-
CLINICAL_TRIALS study record update · 2009-01-23A Phase I Study of Topotecan in Combination With Pemetrexed in Patients With Advanced Malignancies
-
CLINICAL_TRIALS study record update · 2008-11-25A Phase 2, Open-Label, Safety and Efficacy Study of Panzem® Nanocrystal Colloidal Dispersion Administered Orally in Patients With Recurrent or Resistant Epithelial Ovarian Cancer
-
CLINICAL_TRIALS study record update · 2008-11-07A Phase I, Open-Label, Dose-Escalation Study of the Safety and Pharmacokinetics of D4064A Administered Intravenously to Patients With Recurrent or Persistent Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer After a Platinum-Containing Regimen
-
CLINICAL_TRIALS study record update · 2008-10-15A Phase I/II Non-Comparative Study of Paclitaxel Plus Carboplatin in Combination With Vorinostat in Patient With Advanced, Recurrent, Epithelial Ovarian Cancer
-
CLINICAL_TRIALS study record update · 2008-07-24Phase I-II Study Of Docetaxel And Oxaliplatine In Patients With Stage III-IV Ovarian Epithelial Cancer
-
CLINICAL_TRIALS study record update · 2008-07-15A Phase I, Dose Finding, Pharmacokinetic, and Safety Study of Continuous IV Infusion of ECO-4601 in Patients With Advanced Cancer Including an Extension Portion to Obtain Safety Data at the Highest Tolerable Dose
-
CLINICAL_TRIALS study record update · 2008-04-09Ovarian Conservation: Long-Term Health Outcomes From the Nurse's Health Study.
-
CLINICAL_TRIALS study record update · 2008-03-04A Phase I Study of Infusional Chemotherapy With the P-Glycoprotein Antagonist PSC 833
-
CLINICAL_TRIALS study record update · 2008-03-04A Phase I Study of Infusional Paclitaxel With the P-Glycoprotein Antagonist PSC 833
-
CLINICAL_TRIALS study record update · 2008-03-04A Phase I Study of SU5416, an Antiangiogenesis Agent, in Combination With Carboplatin in Patients With Platinum-Refractory Ovarian Cancer
-
CLINICAL_TRIALS study record update · 2008-03-04A Clinical Trial of the P-Glycoprotein Antagonist, XR9576, in Combination With Vinorelbine in Patients With Cancer: Analysis of the Interaction Between XR9576 and Vinorelbine
-
CLINICAL_TRIALS study record update · 2008-01-03A Phase II Trial of ModifiedTriple Doublet Therapy in the Treatment of Women With Newly Diagnosed Carcinoma of Müllerian Origin
-
CLINICAL_TRIALS study record update · 2007-12-18A Double-Blind, Placebo-Controlled, Multicenter Clinical Trial of Intravenous OvaRex® MAb-B43.13 as Post Chemotherapy Consolidation for Epithelial Carcinoma of Ovarian, Tubal or Peritoneal Origin
-
CLINICAL_TRIALS study record update · 2007-12-18An Open-Label, Phase II Study of Ovarex® MAb-B43.13 as an Adjuvant Treatment to Platinum-Based Front-Line Chemotherapy of Advanced Epithelial Carcinoma of Ovarian, Tubal, or Peritoneal Origin
-
CLINICAL_TRIALS study record update · 2007-09-21Randomized, Double-Blind, Phase III Trial of Chemotherapy Plus the Transcriptional Therapy Hydralazine and Magnesium Valproate Versus Chemotherapy Plus Placebo in Cisplatin-Resistant Recurrent Ovarian Cancer.
-
CLINICAL_TRIALS study record update · 2007-09-11Adjuvant Whole Abdominal Intensity Modulated Radiotherapy (IMRT) for High Risk Stage FIGO III Patients With Ovarian Cancer: Pilot Trial of a Phase I/II Study
-
CLINICAL_TRIALS study record update · 2007-08-17A Phase II Study Designed to Evaluate the Safety and Efficacy of the Addition of Herceptin to a Carboplatin-Paclitaxel Regimen in Early Relapse Patients (< 6 Months) With Ovarian Cancer, Overexpressing HER2, Previously Treated With Carboplatin-Paclitaxel
-
CLINICAL_TRIALS study record update · 2007-08-13The Development of Human Immunologic Assays Specific to Folate Receptor Antigen
-
CLINICAL_TRIALS study record update · 2007-05-25Continuation of Treatment and Monitoring of Safety in Patients Treated With LY353381 for Advanced Cancer